Literature DB >> 25298257

Instrumental variable additive hazards models.

Jialiang Li1,2,3, Jason Fine4, Alan Brookhart5.   

Abstract

Instrumental variable (IV) methods are popular in non-experimental studies to estimate the causal effects of medical interventions. These approaches allow for the consistent estimation of treatment effects even if important confounding factors are unobserved. Despite the increasing use of these methods, there have been few extensions of IV methods to censored data problems. In this article, we discuss challenges in applying IV techniques to the proportional hazards model and demonstrate the utility of the additive hazards formulation for IV analyses with censored data. Assuming linear structural equation models for the hazard function, we develop a closed-form, two-stage estimator for the causal effect in the additive hazard model. The methods permit both continuous and discrete exposures, and enable the estimation of causal relative survival measures. The asymptotic properties of the estimators are derived and the resulting inferences are shown to perform well in simulation studies and in an application to a data set on the effectiveness of a novel chemotherapeutic agent for colon cancer.
© 2014, The International Biometric Society.

Entities:  

Keywords:  Additive hazards model; Instrumental variable; Survival analysis; Two-stage least squares estimation

Mesh:

Substances:

Year:  2014        PMID: 25298257     DOI: 10.1111/biom.12244

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  20 in total

1.  Reader reaction: Instrumental variable additive hazards models with exposure-dependent censoring.

Authors:  Kwun Chuen Gary Chan
Journal:  Biometrics       Date:  2016-01-11       Impact factor: 2.571

2.  Causal inference in randomized clinical trials.

Authors:  Cheng Zheng; Ran Dai; Robert Peter Gale; Mei-Jie Zhang
Journal:  Bone Marrow Transplant       Date:  2019-03-26       Impact factor: 5.483

3.  Instrumental variable with competing risk model.

Authors:  Cheng Zheng; Ran Dai; Parameswaran N Hari; Mei-Jie Zhang
Journal:  Stat Med       Date:  2017-01-08       Impact factor: 2.373

4.  Causal mediation analysis on failure time outcome without sequential ignorability.

Authors:  Cheng Zheng; Xiao-Hua Zhou
Journal:  Lifetime Data Anal       Date:  2016-07-27       Impact factor: 1.588

5.  Weighted estimators of the complier average causal effect on restricted mean survival time with observed instrument-outcome confounders.

Authors:  Sai H Dharmarajan; Yun Li; Douglas Lehmann; Douglas E Schaubel
Journal:  Biom J       Date:  2020-12-21       Impact factor: 2.207

6.  Instrumental variables estimation of exposure effects on a time-to-event endpoint using structural cumulative survival models.

Authors:  Torben Martinussen; Stijn Vansteelandt; Eric J Tchetgen Tchetgen; David M Zucker
Journal:  Biometrics       Date:  2017-05-10       Impact factor: 2.571

7.  Instrumental variable estimation in a survival context.

Authors:  Eric J Tchetgen Tchetgen; Stefan Walter; Stijn Vansteelandt; Torben Martinussen; Maria Glymour
Journal:  Epidemiology       Date:  2015-05       Impact factor: 4.822

8.  Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.

Authors:  Rishi J Desai; Mufaddal Mahesri; Younathan Abdia; Julie Barberio; Angela Tong; Dongmu Zhang; Panagiotis Mavros; Seoyoung C Kim; Jessica M Franklin
Journal:  JAMA Netw Open       Date:  2018-07-06

9.  Instrumental variable approach for estimating a causal hazard ratio: application to the effect of postmastectomy radiotherapy on breast cancer patients.

Authors:  Fan Yang; Jing Cheng; Dezheng Huo
Journal:  Obs Stud       Date:  2019-10-18

10.  Estimating the Causal Effect of Treatment in Observational Studies with Survival Time Endpoints and Unmeasured Confounding.

Authors:  Jaeun Choi; A James O'Malley
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2016-06-27       Impact factor: 1.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.